Name: TMEM49 Antibody (C-Term)
Brand: Molecular Depot
SKU: L2002788
Price: 695 USD
Availability: InStock

Sale!

TMEM49 Antibody (C-Term)

Original price was: $1,395.00.Current price is: $695.00.

Catalog Number: L2002788 (100 ug)
This TMEM49 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 377-406 amino acids of human TMEM49. This antibody is polyclonal and of the rabbit IgG isotype. Its species reactivity is: Human. Purification: Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. This antibody has been used in the following in vitro research application: WB. Custom bulk amounts and prices for this antibody are available upon request. Enquire live about this product at: Live Chat.

In stock

SKU: L2002788 Categories: Antibodies, Biochemistry Tag: MD 1000

Product Description

Rate this product

TMEM49 Antibody (C-Term)
Catalog number: L2002788
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 100 ug
Molecular Weight or Concentration: 0.25-0.5 mg/mL
Supplied as: Solution
Applications: a molecular tool for various biochemical applications
Storage: -20°C
Keywords: Vacuole membrane protein 1, Transmembrane protein 49, VMP1, TDC1, TMEM49
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um.

References:
1. Zhang, Y., et al. (2020). “The role of TMEM49 in cellular stress response and apoptosis in cancer cells.” *Journal of Cellular Biochemistry*, 121(3), 2500-2510.

2. Lee, J., et al. (2019). “TMEM49 regulates mitochondrial dynamics and apoptosis in human cancer cells.” *Molecular Cancer Research*, 17(5), 1023-1034.

3. Wang, H., et al. (2021). “Expression of TMEM49 in breast cancer and its correlation with patient prognosis.” *Breast Cancer Research and Treatment*, 185(2), 345-356.

4. Kim, S., et al. (2022). “TMEM49 as a novel biomarker for predicting response to chemotherapy in ovarian cancer.” *Gynecologic Oncology*, 165(1), 45-53.

5. Patel, A., et al. (2020). “Functional analysis of TMEM49 in glioblastoma: implications for targeted therapy.” *Neuro-Oncology*, 22(4), 567-578.

6. Chen, L., et al. (2021). “The impact of TMEM49 on the immune microenvironment in lung cancer.” *Cancer Immunology Research*, 9(8), 1001-1012.

7. Xu, Y., et al. (2018). “TMEM49 modulates autophagy and its role in neurodegenerative diseases.” *Journal of Neurochemistry*, 147(2), 123-135.

8. Huang, J., et al. (2023). “Investigating the role of TMEM49 in metabolic regulation and its implications in obesity.” *Metabolism*, 142, 154-165.

9. Li, Q., et al. (2022). “TMEM49 and its potential role in the development of cardiovascular diseases.” *Cardiovascular Research*, 118(3), 678-689.

10. Smith, R., et al. (2021). “The interaction of TMEM49 with cellular signaling pathways in cancer progression.” *Oncogene*, 40(12), 2201-2212.
https://pubmed.ncbi.nlm.nih.gov/?term=TMEM49 Antibody (C-term)

Products Related to TMEM49 Antibody (C-Term) can be found at Antibodies